Akira Matsumura,Tomoyuki Asano, Katsumi Hirose, Hiroshi Igaki, Shinji Kawabata, and Hiroaki Kumada
Abstract
Boron neutron capture therapy (BNCT) has been performed at nuclear research reactors for many years. The development of accelerators for BNCT resulted in a paradigm shift from research to real clinical applications. In Japan, BNCT was approved as a clinical therapy covered by the National Health Insurance in 2020. In this article, the status of BNCT in Japan is briefly introduced.
